<section class="slide" data-slide-id="S21">
        <h2 style="font-family: Georgia, serif; font-size: 3vw; color: var(--navy); margin-bottom: 0.5vw; line-height: 1.2;">
            Aplicação GRADE: <span style="color: var(--gold);">Ácido Bempedóico</span>
        </h2>

        <div style="display: grid; grid-template-columns: 1.2fr 0.8fr; gap: 2vw; margin-top: 2vw;">
            
            <!-- COLUNA ESQUERDA: RECOMENDAÇÕES -->
            <div style="display: flex; flex-direction: column; gap: 2vw;">
                
                <!-- RECOMENDAÇÃO 1: INTOLERÂNCIA + EZETIMIBA -->
                <div style="background: var(--white); border: 2px solid var(--teal); border-radius: 0.5vw; padding: 2vw;">
                    <div style="display: flex; align-items: center; gap: 1vw; margin-bottom: 1.5vw;">
                        <div style="background: var(--gold); color: var(--navy); width: 2.5vw; height: 2.5vw; border-radius: 50%; display: flex; align-items: center; justify-content: center; font-family: Lato, sans-serif; font-size: 1.5vw; font-weight: bold;">
                            1
                        </div>
                        <h3 style="font-family: Lato, sans-serif; font-size: 1.3vw; color: var(--text); margin: 0; font-weight: bold; text-transform: uppercase;">
                            INTOLERÂNCIA + EZETIMIBA
                        </h3>
                    </div>
                    
                    <p style="font-family: Georgia, serif; font-size: 1.15vw; line-height: 1.6; color: var(--text); margin: 0 0 1.2vw 0; font-style: italic;">
                        "Em indivíduos <strong>intolerantes a estatinas</strong> e que não atingem o alvo a despeito de ezetimiba, recomenda-se a favor de <strong>intensificação terapêutica com ácido bempedóico</strong>."
                    </p>
                    
                    <div style="display: flex; gap: 0.8vw;">
                        <span style="padding: 0.4vw 0.8vw; border-radius: 0.3vw; font-family: Lato, sans-serif; font-size: 0.8vw; font-weight: 900; color: white; background: var(--gold); text-transform: uppercase;">FORTE</span>
                        <span style="padding: 0.4vw 0.8vw; border-radius: 0.3vw; font-family: Lato, sans-serif; font-size: 0.8vw; font-weight: 900; color: white; background: var(--teal); text-transform: uppercase;">ALTA</span>
                    </div>
                </div>

                <!-- RECOMENDAÇÃO 2: ASSOCIAÇÃO ESTATINA + EZETIMIBA -->
                <div style="background: var(--white); border: 2px solid var(--teal); border-radius: 0.5vw; padding: 2vw;">
                    <div style="display: flex; align-items: center; gap: 1vw; margin-bottom: 1.5vw;">
                        <div style="background: var(--gold); color: var(--navy); width: 2.5vw; height: 2.5vw; border-radius: 50%; display: flex; align-items: center; justify-content: center; font-family: Lato, sans-serif; font-size: 1.5vw; font-weight: bold;">
                            2
                        </div>
                        <h3 style="font-family: Lato, sans-serif; font-size: 1.3vw; color: var(--text); margin: 0; font-weight: bold; text-transform: uppercase;">
                            ASSOCIAÇÃO (ALTO RISCO)
                        </h3>
                    </div>
                    
                    <p style="font-family: Georgia, serif; font-size: 1.15vw; line-height: 1.6; color: var(--text); margin: 0 0 1.2vw 0; font-style: italic;">
                        "Em indivíduos que não atingirem a meta terapêutica com <strong>estatina de alta intensidade e ezetimiba</strong>, recomenda-se a favor de adicionar <strong>terapia anti-PCSK9 ou ácido bempedóico</strong>, conforme a meta terapêutica."
                    </p>
                    
                    <div style="display: flex; gap: 0.8vw;">
                        <span style="padding: 0.4vw 0.8vw; border-radius: 0.3vw; font-family: Lato, sans-serif; font-size: 0.8vw; font-weight: 900; color: white; background: var(--gold); text-transform: uppercase;">FORTE</span>
                        <span style="padding: 0.4vw 0.8vw; border-radius: 0.3vw; font-family: Lato, sans-serif; font-size: 0.8vw; font-weight: 900; color: white; background: var(--teal); text-transform: uppercase;">ALTA</span>
                    </div>
                </div>

            </div>

            <!-- COLUNA DIREITA: GRAMÁTICA GRADE -->
            <div style="background: var(--navy); color: var(--white); border-radius: 0.5vw; padding: 2vw;">
                <h3 style="font-family: Lato, sans-serif; font-size: 1.2vw; color: var(--gold); margin: 0 0 1.5vw 0; font-weight: bold; text-transform: uppercase; letter-spacing: 0.05vw;">
                    GRAMÁTICA GRADE:
                </h3>

                <!-- BASELINE -->
                <div style="margin-bottom: 2vw;">
                    <p style="font-family: Lato, sans-serif; font-size: 0.95vw; color: var(--gold); margin: 0 0 0.5vw 0; font-weight: bold;">
                        Baseline:
                    </p>
                    <p style="font-family: Lato, sans-serif; font-size: 1.1vw; color: var(--white); margin: 0; line-height: 1.4;">
                        <span style="font-size: 1.3vw; margin-right: 0.5vw;">⊕⊕⊕⊕</span>
                        <span style="color: var(--teal); font-weight: bold;">ALTA</span>
                    </p>
                    <p style="font-family: Lato, sans-serif; font-size: 0.85vw; color: rgba(255,255,255,0.7); margin: 0.5vw 0 0 0; line-height: 1.3; font-style: italic;">
                        CLEAR Outcomes: RCT duplo-cego, N=13.970
                    </p>
                </div>

                <div style="height: 1px; background: rgba(255,255,255,0.2); margin: 1.5vw 0;"></div>

                <!-- DOWNGRADE -->
                <div style="margin-bottom: 2vw;">
                    <p style="font-family: Lato, sans-serif; font-size: 0.95vw; color: #DC2626; margin: 0 0 0.8vw 0; font-weight: bold;">
                        Downgrade: (-1)
                    </p>
                    <p style="font-family: Lato, sans-serif; font-size: 0.9vw; color: rgba(255,255,255,0.9); margin: 0; line-height: 1.3;">
                        <strong style="color: var(--gold);">Domínio: IMPRECISÃO</strong><br>
                        IC 95% toca MID (0,79–0,96)<br>
                        Limite inferior próximo do nulo
                    </p>
                </div>

                <div style="height: 1px; background: rgba(255,255,255,0.2); margin: 1.5vw 0;"></div>

                <!-- RESULTADO FINAL -->
                <div style="background: rgba(37, 99, 235, 0.2); border: 2px solid var(--blue); border-radius: 0.4vw; padding: 1.2vw; margin-bottom: 1.5vw;">
                    <p style="font-family: Lato, sans-serif; font-size: 0.9vw; color: var(--gold); margin: 0 0 0.5vw 0; font-weight: bold; text-transform: uppercase;">
                        Certeza da Evidência:
                    </p>
                    <p style="font-family: Lato, sans-serif; font-size: 1.2vw; color: var(--white); margin: 0; font-weight: bold;">
                        <span style="font-size: 1.4vw; margin-right: 0.5vw;">⊕⊕⊕⊝</span>
                        <span style="background: var(--blue); padding: 0.3vw 0.8vw; border-radius: 0.3vw;">MODERADA</span>
                    </p>
                </div>

                <!-- POR QUE FORTE? -->
                <div style="background: rgba(221, 185, 68, 0.15); border-left: 3px solid var(--gold); padding: 1vw; border-radius: 0.3vw;">
                    <p style="font-family: Lato, sans-serif; font-size: 0.85vw; color: var(--gold); margin: 0 0 0.5vw 0; font-weight: bold; text-transform: uppercase;">
                        Por que FORTE?
                    </p>
                    <p style="font-family: Lato, sans-serif; font-size: 0.85vw; color: rgba(255,255,255,0.9); margin: 0; line-height: 1.4;">
                        • Benefício CV claro (↓13% MACE)<br>
                        • Alternativa = sem terapia<br>
                        • Valores: evitar SAMS prioritário<br>
                        • Perfil segurança favorável
                    </p>
                </div>

            </div>

        </div>

        <!-- RODAPÉ -->
        <div style="position: absolute; bottom: 1vw; left: 2vw; right: 2vw; padding-top: 0.8vw; border-top: 1px solid var(--border);">
            <p style="font-family: Lato, sans-serif; font-size: 0.75vw; color: var(--muted); margin: 0; line-height: 1.3;">
                <strong>Evidência:</strong> Nissen SE et al. NEJM 2023;388(15):1353-1364 (CLEAR Outcomes) | <strong>Diretriz:</strong> Rached FH et al. Arq Bras Cardiol. 2025;122(9):e20250640
            </p>
        </div>
    </section>